A comparative study for efficacy and safety between Zitux (Rituximab manufactured by AryoGen) and Mabthera on patients with chronic lymphocytic leukemia (CLL)
Double blind? Randomized clinical trial of the efficacy of Aryogen Trastuzumab compared to Genentech/roche Trastuzumab in breast cancer
Comparing the cost-effectiveness of two alternative bypassing agents (aryoseven & feiba) for patients with hemophilia A complicated by an inhibitor in Iran
100 Clinical Results associated with Aryogen Biopharma
0 Patents (Medical) associated with Aryogen Biopharma
100 Deals associated with Aryogen Biopharma
100 Translational Medicine associated with Aryogen Biopharma